Gelteq Ltd (GELS) stock
GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.27−0.09 (-25.05%)
Close on Nov 17, 2026Market cap $2.88MP/E –Yield –
Gelteq cash
Cash and short-term investments held at the end of each period.
Gelteq's cash was A$9.35K at Dec 31, 2025. For fiscal 2025 it was A$344.65K, up 1305.5% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | A$344.65K | +1305.5% |
| FY2024 | Jun 30, 2024 | A$24.52K | -93.9% |
| FY2023 | Jun 30, 2023 | A$399.22K | +145.7% |
| FY2022 | Jun 30, 2022 | A$162.49K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | A$9.35K | -92.6% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | A$344.65K | -13.7% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | A$3.05M | +1775.0% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | A$24.52K | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | A$126.78K | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | A$399.22K | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | A$162.49K | – |
See a number that looks wrong?